Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

Inclusion Criteria: * Asthmatic patients treated for this disease with Symbicort Turbuhaler * Patients monitored for asthma by the doctor for at least 12 months * Patients seen in outpatient care at the baseline visit * Patients agreeing to participate in the study Exclusion Criteria: * Patients with any chronic lower respiratory disease other than asthma * Patients receiving anti-IgE agents in the last 4 months * Patients receiving desensitisation treatment outside of the maintenance phase * Patients deemed to be unable to respond to the study for linguistic or cognitive reasons